Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Scope: This study aims to investigate the anticancer properties of Citrus grandis 'Tomentosa' (CGT) in non-small cell lung cancer (NSCLC).
Methods And Results: The ethanol extract of CGT (CGTE) is prepared by using anhydrous ethanol and analyzed by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), revealing that the main chemical components in CGTE are flavonoids and coumarins, such as naringin, rhoifolin, apigenin, bergaptol, and osthole. CGTE at concentrations without inducing cell death significantly inhibits cell proliferation via inducing cell cycle G1 phase arrest by MTT, colony formation, and flow cytometry assays, implying that CGT has anticancer potential. CGTE markedly inhibits the activity of Skp2-SCF E3 ubiquitin ligase, decreases the protein level of Skp2, and promotes the accumulation of p27 by co-immunoprecipitation (co-IP) and in vivo ubiquitination assay; whereas Skp2 overexpression rescues the effects of CGTE in NSCLC cells. In subcutaneous LLC allograft and A549 xenograft mouse models, CGTE, without causing obvious side effects in mice, significantly inhibits lung tumor growth by targeting the Skp2/p27 signaling pathway.
Conclusion: These findings demonstrate that CGTE efficiently inhibits NSCLC proliferation both in vitro and in vivo by targeting the Skp2/p27 signaling pathway, suggesting that CGTE may serve as a therapeutic candidate for NSCLC treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mnfr.202300061 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
BAF312 Inhibits the Growth of Glioma and Promotes the Normalization of Tumor Blood Vessels.
FASEB J
August 2025
Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
This study investigates the repurposing of BAF312 (Siponimod), an FDA-approved sphingosine-1-phosphate (S1P) receptor agonist for multiple sclerosis, as a dual-targeting therapeutic agent for glioma by inhibiting tumor growth and normalizing aberrant tumor vasculature. The clinical correlations between S1PR1/5 expression and glioma prognosis were analyzed using the GEPIA and HPA databases. The effects of BAF312 on tumor growth, cell cycle progression, apoptosis, and vascular remodeling were evaluated using orthotopic GL261 glioma models and glioma cell lines (U118MG, T98G, GL261).
View Article and Find Full Text PDFARv7 promotes the escape of prostate cancer cells from androgen deprivation therapy-induced senescence by mediating the SKP2/p27 axis.
BMC Biol
February 2025
Department of Biochemistry & Molecular Biology, College of Basic Medical Sciences, Jilin University, Changchun, 130021, China.
Background: Androgen deprivation therapy (ADT) induces cellular senescence and tumor stasis, thus serving as the standard treatment for prostate cancer (PCa). However, continuous suppression of canonical androgen receptor signaling actually leads to the switch from androgen-responsive growth to androgen-independent growth, contributing to "escape" from this ADT-induced senescence (AIS) and, subsequently, the development of castration-resistant prostate cancer (CRPC). Unfortunately, the mechanism underlying this phenomenon remains elusive.
View Article and Find Full Text PDFUpregulated SKP2 Empowers Epidermal Proliferation Through Downregulation of P27 Kip1.
Ann Dermatol
October 2024
State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Article Synopsis
- The study investigates the role of S-phase kinase-associated protein 2 (SKP2) in the hyperproliferation of keratinocytes, which is a key factor in the development of psoriasis.
- The researchers analyzed gene expression data and confirmed increased levels of SKP2 in psoriatic skin tissues and stimulated keratinocytes, suggesting its involvement in disease progression.
- The findings indicate that high SKP2 levels promote keratinocyte proliferation by inhibiting the expression of another protein, P27 Kip1, and show that targeting SKP2 could potentially reduce skin hyperplasia associated with psoriasis.
Comprehensive single cell transcriptomics analysis of murine osteosarcoma uncovers function in metastasis, genomic instability and immune activation and reveals additional target pathways.
bioRxiv
June 2024
Department of Orthopedic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Article Synopsis
- Osteosarcoma is the most prevalent bone cancer in children, and new research targets specific molecular pathways to improve treatment outcomes through enhanced apoptosis and reduced tumor inflammation.
- Using single-cell RNA sequencing, researchers found that a transgenic mouse model effectively mirrors the tumor characteristics and microenvironment seen in human osteosarcoma, highlighting the importance of specific gene knockouts in reducing T cell exhaustion and promoting interferon activation.
- The study suggests mechanisms of tumor escape from treatment, such as gene overexpression and alternative pathways, providing insights that could lead to the development of innovative therapies for osteosarcoma.
Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.
Cell Death Dis
April 2024
College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian, 350108, P. R. China.
Soft-tissue sarcomas (STS) emerges as formidable challenges in clinics due to the complex genetic heterogeneity, high rates of local recurrence and metastasis. Exploring specific targets and biomarkers would benefit the prognosis and treatment of STS. Here, we identified RCC1, a guanine-nucleotide exchange factor for Ran, as an oncogene and a potential intervention target in STS.
View Article and Find Full Text PDF